SCHEMBL734137

SCHEMBL734137

CC(c1cc(Oc2ccc(F)c(C(=O)O)c2)ccc1Cl)C(O)(c1ccc(=O)n(C)c1)C(F)(F)F

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 1/20 0.34
P2RX3 P56373 1/20 0.34
MET P08581 1/20 0.33
ALK Q9UM73 1/20 0.33
MEN1 O00255 1/20 0.33
TTR P02766 1/20 0.33
PPOX P50336 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
NR3C1 P04150 6/20 0.33
ADRB1 P08588 1/20 0.33
ADRB3 P13945 1/20 0.33
BRD4 O60885 1/20 0.32
SCN8A Q9UQD0 1/20 0.31
SCN10A Q9Y5Y9 1/20 0.31
ENPP2 Q13822 1/20 0.31
THRA P10827 1/20 0.31
THRB P10828 1/20 0.31
TLR8 Q9NR97 1/20 0.30
PPARG P37231 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL753316 1.00 MRGPRX4 (0.34) MRGPRX4P2RX3METALKMEN1
SCHEMBL752343 0.94 MEN1 (0.34) MRGPRX4MEN1TTRPPOXKMT2A
SCHEMBL733020 0.94 MEN1 (0.34) MRGPRX4MEN1TTRPPOXKMT2A
SCHEMBL732524 0.93 P2RX3 (0.34) MRGPRX4P2RX3METALKMEN1
SCHEMBL754912 0.93 P2RX3 (0.34) MRGPRX4P2RX3METALKMEN1
SCHEMBL480085 0.91 S1PR2 (0.34) MEN1TTRPPOXKMT2ATDP1
SCHEMBL753070 0.91 S1PR2 (0.34) MEN1TTRPPOXKMT2ATDP1
SCHEMBL754922 0.90 BAZ2B (0.41) MRGPRX4P2RX3METALKNR3C1
SCHEMBL480108 0.90 BAZ2B (0.41) MRGPRX4P2RX3METALKNR3C1
SCHEMBL733354 0.86 P2RX3 (0.35) MRGPRX4P2RX3METALKNR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411361-B1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2014-06-18 EP claimed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US claimed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US claimed
EP-2411361-B1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2014-06-18 EP disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, CRHR1 MRGPRX4 284/4885P2RX3 696/4885MET 1104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.